Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

4.5%

2 terminated/withdrawn out of 44 trials

Success Rate

89.5%

+3.0% vs industry average

Late-Stage Pipeline

23%

10 trials in Phase 3/4

Results Transparency

6%

1 of 17 completed trials have results

Key Signals

10 recruiting1 with results

Enrollment Performance

Analytics

N/A
19(57.6%)
Phase 3
7(21.2%)
Phase 1
3(9.1%)
Phase 4
3(9.1%)
Phase 2
1(3.0%)
33Total
N/A(19)
Phase 3(7)
Phase 1(3)
Phase 4(3)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (44)

Showing 20 of 44 trials
NCT07566806Not ApplicableRecruiting

Evaluation of the Clinical Efficacy and Mechanisms of Cord Plasma Eye Drops in the Treatment of Neuropathic Corneal Pain

Role: lead

NCT07567898Not ApplicableNot Yet Recruiting

Effectiveness of Multidisciplinary Protocolised Interventions on IVT Non-adherence Rates

Role: lead

NCT01252654Completed

Comparison of Intralase and Visumax Femtosecond Laser for Laser In Situ Keratomileusis

Role: lead

NCT07505264Not ApplicableRecruiting

Comparison of Myopic Small Incision Lenticule Extraction (SMILE) With VISUMAX 500 Versus VISUMAX 800 Platforms

Role: lead

NCT06877988Not ApplicableActive Not Recruiting

Artificial Intelligence (AI) - Assisted Visual Impairment Screening Model: Community-based Implementation and Evaluation of Performance, Feasibility and Costs.

Role: lead

NCT07243665Not ApplicableRecruiting

Glaucoma Screening Using Artificial Intelligence Assisted Clinical Model in Singapore's Diabetic Eye Screening Program

Role: lead

NCT07364929Not ApplicableRecruiting

Altered Non-Visual Photoreception in Patients With Glaucoma: Impacts on Sleep, Alertness, Mood, and Cognition

Role: collaborator

NCT07174739Not ApplicableRecruiting

Efficacy of Quantum Molecular Resonance in Neuropathic Corneal Pain and Corneal Nerve Regeneration

Role: lead

NCT04319848Phase 1Recruiting

Safety and Efficacy of Tissue Engineered Endothelial Keratoplasty

Role: lead

NCT03351894Not ApplicableCompleted

Comparison of Clinical Outcomes in Ziemer Femtosecond Versus Conventional Phacoemulsification Surgery

Role: lead

NCT06983652Recruiting

Validation of the Use of Terahertz Scanning System on Corneal Scars and Corneal Edema

Role: lead

NCT06967792Recruiting

Evaluation of the Safety of Terahertz Scanning System on Corneas

Role: lead

NCT06048380Phase 3Recruiting

The Effects of Ripasudil in Patients With FED Undergoing Femtosecond Laser Assisted Cataract Surgery

Role: lead

NCT06774651Recruiting

Comparison of Femto LDV Z8 Corneal Lenticule Extraction for Advanced Refractive Correction (CLEAR) and Visumax Small Incision Lenticule Extraction (SMILE)

Role: lead

NCT06731582Phase 3Enrolling By Invitation

Nicotinamide Supplementation in Glaucoma

Role: lead

NCT05809674Completed

Polarization Sensitive Optical Coherence Tomography

Role: lead

NCT05787990Unknown

Time-In-Range Based Risk Stratification of Type 2 Diabetes Microvascular Complications

Role: collaborator

NCT05651490Not ApplicableUnknown

Problem Solving Treatment for Diabetes in Individuals With Poor Diabetes Control

Role: lead

NCT05626517Not Yet Recruiting

JARVISDHL Screening Tools

Role: collaborator

NCT04636918Phase 4Unknown

Ikervis for DED Due to GVHD Post Allo-HSCT

Role: lead